Brokerages Set Ovid Therapeutics Inc. (NASDAQ:OVID) Price Target at $2.78
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the […]
